Abstract:Objective To construct eukaryotic expression vector containing the extracellular domain of the human AChRα1-subunit(Hα1-210) and Fc fragment of human IgG1,and to express human AChR-Fc fusion protein.Methods The extracellular domain of Hα1-210 was amplified and inserted into pAN1782 eukaryotic expression vector with a cytomegalovirus promoter,a murine immunoglobulin κ-chain leader sequence and the human genomic IgG γ1 constant region from the hinge to the end of CH3.Recombinant expression vector pAN-Hα1-210 was constructed and evaluated by restriction enzyme analysis and sequencing.The right pAN-Hα1-210 plasmid was transfected into CHO-K1 cells with lipofectin reagent and selected by G418.The positive clone with high expressing fusion protein were selected through ELISA detection and cultured.After purified by protein A affinity column chromatography,the AChR-Fc fusion protein was identified by SDS-PAGE and Western blot assay.Results Restriction enzyme and sequencing indicated Hα1-210 gene sequence was correct and pAN-Hα1-210 had been constructed successfully.AChR-Fc fusion protein could be detected by ELISA assay in the CHO-K1 culture supernatant.There was only one special band at the position of relative molecular mass 51 000 by SDS-PAGE assay,and it was equivalent to expected value.Western blot analysis also showed that fusion protein could react to mAb198.Conclusions We successfully constructed eukaryotic expression vector pAN-Hα1-210 and obtained AChR-Fc fusion protein with biological activity,thus lay a foundation for further works on the treatment of myasthenia gravis(MG) by targeting B cells.

Preparation of human monoclonal antibodies against acetylcholine receptor in human immunoglobulin loci transgenic mice

Preparation and Identification of Monoclonal Antibody Against Human Testis Development Related Gene 1

Potential Roles of Recombinant Acetylcholine Receptor Α Subunit 1–211 in Immunoadsorbent and DNA Immunization

Experimental autoimmune myasthenia gravis in mice expressing human immunoglobulin loci

Artificial Construction of Human Pathogenic Autoantibody in Myasthenia Gravis

Construction and Characterization of a Human Anti-Acetylcholine Receptor Autoantibody

Removal of Complement Binding Activity of an Anti-Acetylcholine Receptor Antibody by Site Directed Mutagenesis

Construction and Expression of a Human/mouse Chimeric CD19 Monoclonal Antibody: Successful Modification of a Murine IgM to a Chimeric IgG.

Preparation and identification of monoclonal antibodies against Luman-recruiting factor N-terminal

Construction and Expression of a Fusion Protein Containing Extracellular Domain of Human AChRα1 and Fc Fragment of Human IgG1

Preparation and Characterization of Monoclonal Antibodies Against Trypsingen Activation Peptides

Preparation and Identification of Monoclonal Antibodies Against Humanin

Preparation and Characterization of Monoclonal Antibody Against Human Leukocytes

Pathogenesis of Myasthenia Gravis in Transgenic Mouse Induced with Torpedo Acetylcholine Receptor

Preparation and immunological properties identification of monoclonal antibodies against Oratosquilla oratoria de Haan TM allergen

[Preparation and Application of Monoclonal Antibody Against Human Myoglobin].

Preparation and identification of monoclonal antibody against human Grn E

[Preparation and application of polyclonal antibody against mouse IL-1α]

Construction of a myasthenia gravis model by immunizing mice with gene vaccine pcDNA-AChR_(α211)

Preparation of an immunoadsorbent coupled with a recombinant antigen to remove anti-acetylcholine receptor antibodies in abnormal serum.

Preparation of a Novel Functional Mouse Anti-Human 2Igb7-H3 Antibody and Primary Study of Its Biological Characteristics.